NextCure Inc Cash Flow-to-Debt Ratio
NextCure Inc cash flow-to-debt ratio. NextCure Inc (NXTC) has a Cash Flow-to-Debt Ratio of -0.93x as of June 2026, meaning its operating cash flow of $-9.71 Million could theoretically repay -1% of its total liabilities ($10.47 Million) in one year. Check NextCure Inc (NXTC) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of NextCure Inc (2017–2025)
Cash flow-to-debt ratio of NextCure Inc from 2017 to 2025. Historical debt coverage capacity for NextCure Inc across 9 annual periods. Check NextCure Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
NextCure Inc Cash Flow-to-Debt Ratio by Year (2017–2025)
NextCure Inc cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for NextCure Inc. For the full cash flow conversion analysis, see NXTC operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.26x | $-49.61 Million | $15.24 Million | ▼ -22.8% |
| 2024 | -2.65x | $-40.80 Million | $15.39 Million | ▲ +31.8% |
| 2023 | -3.89x | $-52.97 Million | $13.62 Million | ▼ -20.1% |
| 2022 | -3.24x | $-53.89 Million | $16.63 Million | ▲ +49.1% |
| 2021 | -6.36x | $-57.24 Million | $9.00 Million | ▼ -82.8% |
| 2020 | -3.48x | $-44.95 Million | $12.92 Million | ▼ -238.7% |
| 2019 | -1.03x | $-35.62 Million | $34.68 Million | ▼ -2600.5% |
| 2018 | 0.04x | $7.99 Million | $194.57 Million | ▲ +114.4% |
| 2017 | -0.29x | $-12.51 Million | $43.88 Million | — |